Putting Theory into Practice at BridgeBio.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 48, doi. 10.5912/jcb991
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2021 AND VI 26 AND IP 2
Results: 11
1
2
Building Technology Enabled Platform Companies in Biopharma - A Perspective on Early-Stage Value Creation from Millennium, Alnylam, Moderna, & Kymera.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 36, doi. 10.5912/jcb990
- By:
- Publication type:
- Article
3
A Note on Corporate Open Innovation: Engagement with Startups.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 33, doi. 10.5912/jcb989
- By:
- Publication type:
- Article
4
A Case Study - NeuBase Therapeutics, Inc.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 67, doi. 10.5912/jcb995
- By:
- Publication type:
- Article
5
Illumina Accelerator: Next-Gen Corporate Accelerator with a Customer-Creation Focus.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 55, doi. 10.5912/jcb993
- By:
- Publication type:
- Article
6
Abridge: A Mission Driven Approach to Machine Learning for Healthcare Conversation.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 62, doi. 10.5912/jcb994
- By:
- Publication type:
- Article
7
Foundational Tools for Building a New Bioeconomy.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 52, doi. 10.5912/jcb992
- By:
- Publication type:
- Article
8
The Code Breaker: Jennifer Doudna, Gene Editing, and The future of the Human Race.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 26, doi. 10.5912/jcb988
- By:
- Publication type:
- Article
9
Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 20, doi. 10.5912/jcb987
- By:
- Publication type:
- Article
10
Companies Recognized as Innovators for 2021.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 13, doi. 10.5912/jcb986
- By:
- Publication type:
- Article
11
Introduction, Rationale and Commentary on Recognizing and Celebrating Innovation in Our Industry.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 3, doi. 10.5912/jcb985
- By:
- Publication type:
- Article